During the pandemic, Benaroya Research Institute at Virginia Mason (BRI) leveraged its expertise in autoimmune disease, allergies and asthma to tackle COVID-19. Results reveal potential ways to predict disease severity and may guide treatment options to improve patient outcomes. BRI…